0 CHECKOUT

PRODUCT FILTERS

REGION

15
3
2
2
1

COUNTRY

1
1

CATEGORIES

  • 58
  • 12
  • 9
  • 7
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

8
44
64
99

PUBLISHED

1
8
25
99

PRODUCT TYPE

51
41
7

Search for: "Crohn's Disease Therapy Area Pipeline Report"

Crohn's Disease Drug Market and Pipeline Analysis

Under the umbrella of inflammatory bowel diseases, Crohn's disease and ulcerative colitis are two most common disorders Though both these disorders have similar symptoms, the difference arises in the...

Published:  May 2014
Price:  From

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2015

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2015 Summary The report ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2015’, provides an overview of the Crohn's Disease (Regional...

Published:  December 2015
Price:  From

Crohn's Disease - Pipeline Review, H1 2015

This report provides comprehensive information on the therapeutic development for Crohn's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism...

Published:  June 2015
Price:  From

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

""Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need"", which provides insights into three therapeutic indications...

Published:  January 2014
Price:  From

Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries

‘Gastrointestinal Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Counter Declines from Patent Expiries' provides insights into three gastrointestinal...

Published:  December 2013
Price:  From

Gastrointestinal Disorder Therapeutics Market to 2017 - Crohn's Disease and Irritable Bowel Syndrome Markets Show Strongest Growth

“Gastrointestinal Disorder Therapeutics Market to 2017 - Crohn's Disease and Irritable Bowel Syndrome Markets Show Strongest Growth” provides in-depth analysis of the drivers and barriers that affect...

Published:  September 2011
Price:  From

The Future of Autoimmune Diseases Therapeutics – Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deal Analysis

“The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis” provides in-depth analysis of unmet needs, drivers and barriers...

Published:  December 2009
Price:  From

Gastrointestinal Disorder Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets

“Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets”, provides in-depth analysis of the unmet needs,...

Published:  June 2010
Price:  From

Adaptive Biotechnologies Corporation - Product Pipeline Analysis, 2013 Update

Summary Adaptive Biotechnologies Corporation (Adaptive) is a biotechnology company. The company develops next generation sequencing assays for the adaptive immune system. It offers immunoSEQ, a suite...

Published:  October 2013
Price:  From

Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies

This report provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection,...

Published:  February 2011
Price:  From

Genisphere Inc. - Product Pipeline Analysis, 2013 Update

Summary Genisphere Inc. (Genisphere) is a biotechnology company. The company manufactures kits used for the ultra-sensitive detection of nucleic acids and proteins. Genisphere's therapeutic areas include...

Published:  October 2013
Price:  From

TAKEDA - Challenges Ahead for its New European President

Post Nycomed and Millenium acquisition, the new leadership of non-Japanese CEO/President Mr Weber will transform Takeda into a truly global Japanese company in the coming years It is however important...

Published:  January 2014
Price:  From

Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development

“Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development” provides insights into the unmet needs...

Published:  July 2011
Price:  From

Microbiome Therapeutics Market, 2015 - 2030

The ‘Microbiome Therapeutics Market, 2015-2030’ report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of products in this area. Imbalance in...

Published:  January 2016
Price:  From

Stem Cell Therapeutics Markets (Cardiovascular and Circulatory Diseases, Endocrine Diseases, Digestive Disorders, Musculoskeletal, Nervous System, Cancer, Others)

Stem cells are anticipated to demonstrate considerable efficacy in clinical treatment and revenues to manufacturers with suitable products.  Kalorama Information’s Stem Cell Therapeutics Markets is...

Published:  October 2014
Price:  From

Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives

The new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic or innovator. The most of the companies are revalidating...

Published:  January 2015
Price:  From

Competitor Analysis - Antibody Therapy of Inflammatory and Autoimmune Diseases

The present Competitive Intelligence Report about Antibody Therapy of Inflammatory and Autoimmune Diseases provides a competitor evaluation in the field of antibody therapeutics used or being developed...

Published:  December 2010
Price:  From

Quanterix Corporation - Product Pipeline Analysis

Summary Quanterix Corporation (Quanterix) is a medical device company, based in the US. The company develops and provides ultra-sensitive detection systems for use in research and in-vitro diagnostics....

Published:  November 2012
Price:  From

Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications

GBI Research, the leading business intelligence provider, has released its latest research, “Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative...

Published:  June 2012
Price:  From

Protagonist Therapeutics Inc. - Product Pipeline Review - 2015

Protagonist Therapeutics Inc. - Product Pipeline Review - 2015 Summary The report ‘Protagonist Therapeutics Inc. - Product Pipeline Review - 2015’, provides an overview of the Protagonist Therapeutics...

Published:  August 2015
Price:  From
Loading Indicator

Our Clients

  • Walgreen's Company
  • Elanco Global
  • Nu Skin Enterprises
  • Kemin Industries, Inc.
  • Suan Farma Inc.
  • Metagenics, Inc.